| Laverock Therapeutics Ltd.. (9/28/23). "Press Release: Laverock Therapeutics Raises £13.5M to Develop Unique Gene Silencing Platform for Programmable Advanced Therapies". |
2023-09-28 |
| Novo Nordisk A/S. (9/25/23). "Press Release: Valo Health and Novo Nordisk to Collaborate to Discover and Develop Novel Treatments for Cardiometabolic Diseases Using Human Data and Artificial Intelligence". Bagsværd & Boston, MA. |
2023-09-25 |
| Biosynth AG. (9/25/23). "Press Release: Biosynth Extends its Offering to Multi-Kilogram GMP Peptide Synthesis through the Acquisition of Pepceuticals". Staad. |
2023-09-25 |
| Exscientia plc. (9/20/23). "Press Release: Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany". Oxford. |
2023-09-20 |
| BenevolentAI. (9/20/23). "Press Release: BenevolentAI Signs Strategic Collaboration with Merck". London. |
2023-09-20 |
| Transimmune AG. (9/20/23). "Press Release: Transimmune Secures $5m Funding to Enhance mRNA Vaccination with Novel Dendritic Cell Therapy". Düsseldorf. |
2023-09-20 |
| BeiGene, Ltd.. (9/19/23). "Press Release: BeiGene Strengthens Global Portfolio and Regains Full Rights from Novartis for Anti-PD-1 Antibody Tevimbra (tislelizumab)". Basel & Beijing & Cambridge, MA. |
2023-09-19 |
| Scinai Immunotherapeutics Ltd.. (9/19/23). "Press Release: Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering". Jerusalem. |
2023-09-19 |
| Rentschler Biopharma SE. (9/19/23). "Press Release: Rentschler Biopharma Appoints Benedikt von Braunmuehl as Chief Executive Officer". Laupheim, Stevenage & Milford, MA. |
2023-09-19 |
| Bruker Corporation. (9/18/23). "Press Release: Bruker Introduces Novel 4D-Proteomics timsTOF Capabilities". Busan. |
2023-09-18 |
| BenevolentAI. (9/18/23). "Press Release: BenevolentAI Welcomes Christina Busmalis as its New Chief Revenue Officer". London. |
2023-09-18 |
| Broken String Biosciences Ltd.. (9/18/23). "Press Release: Broken String Biosciences Closes $15M Series A Funding Round". Cambridge. |
2023-09-18 |
| Atriva Therapeutics GmbH. (9/18/23). "Press Release: Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology". Tübingen & Martinsried. |
2023-09-18 |
| Scinai Immunotherapeutics Ltd.. (9/15/23). "Press Release: Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering". Jerusalem. |
2023-09-15 |
| Merck KGaA. (9/12/23). "Press Release: Merck Appoints Axel Löber as Head of Global Communications and Stakeholder Engagement". Darmstadt. |
2023-09-12 |
| Orbit Discovery Ltd.. (9/11/23). "Press Release: Orano Med and Orbit Discovery Enter Collaboration to Discover Novel Targeted Radioligand Therapies for Cancer". Texas & Oxford. |
2023-09-11 |
| Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA. |
2023-09-11 |
| Scinai Immunotherapeutics Ltd.. (9/11/23). "Press Release: Scinai Immunotherapeutics Ltd. to Participate This Week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston". Jerusalem. |
2023-09-11 |
| BenevolentAI. (9/11/23). "Press Release: Appointment of Catherine Isted, ACMA, as Chief Financial Officer". London. |
2023-09-11 |
| Immatics N.V.. (9/11/23). "Press Release: Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics". Cambridge, MA & Tübingen. |
2023-09-11 |
| Novartis AG. (9/11/23). "Press Release: Sandoz Announces Exclusive Deal to Commercialize Biosimilar Ustekinumab". Basel. |
2023-09-11 |
| Corteria Pharmaceuticals S.A.S.. (9/7/23). "Press Release: Corteria Pharmaceuticals Announces a €65M ($71M) Financing to Advance Transformational Medicines in Cardiovascular Diseases". Paris. |
2023-09-07 |
| Mariana Oncology Inc.. (9/7/23). "Press Release: Mariana Oncology Announces $175 Million Series B Financing". Watertown, MA. |
2023-09-07 |
| Scinai Immunotherapeutics Ltd.. (9/6/23). "Press Release: BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics". Jerusalem. |
2023-09-06 |
| Optibrium Ltd.. (8/31/23). "Press Release: Optibrium Acquires BioPharmics LLC, Expanding Its 3D Drug Design and Visualisation Offering". Cambridge. |
2023-08-31 |
| Exscientia plc. (8/31/23). "Press Release: Exscientia to Present at Upcoming Investor Conferences in September". Oxford. |
2023-08-31 |
| Bayer AG. (8/30/23). "Press Release: Strong Commitment to Modern Crop Protection Made in Europe.
Bayer to Invest EUR 220 Million in New R&D Facility at Its Monheim Site". Monheim. |
2023-08-30 |
| Bayer AG. (8/29/23). "Press Release: Gene Editing – Pairwise and Bayer Start New Five-year Multi-million Dollar Collaboration to Further Advance Short-stature Corn". Durham, NC & Monheim. |
2023-08-29 |
| Golgi Neurosciences S.r.l.. (8/29/23). "Press Release: Golgi Neurosciences Partners with CDD Vault to Drive Innovation in Neurodegenerative Disease Treatment". Milano & San Francisco, CA. |
2023-08-29 |
| Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC. |
2023-08-28 |
| Eppendorf SE. (8/25/23). "Press Release: Automation of Takara Bio’s Chemistries on Eppendorf’s Automated Pipetting Systems for Significantly Higher Efficiency". San José, CA & Hamburg. |
2023-08-25 |
| Synthego Corporation. (8/24/23). "Press Release: Synthego and bit.bio Expand Strategic Partnership to Build a Platform for the Development of Safer and More Efficient Genetic Engineering of Human Cells for Cell Therapies". Redwood City, CA & Cambridge. |
2023-08-24 |
| AiCuris Anti-infective Cures AG. (8/23/23). "Press Release: AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of Prevymis (letermovir) in Second Indication". Wuppertal. |
2023-08-23 |
| Abivax S.A.. (8/23/23). "Press Release: Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations". Paris. |
2023-08-23 |
| Bayer AG. (8/22/23). "Press Release: Bayer Appoints Dr. Juergen Eckhardt as New Head of Pharmaceuticals Business Development & Licensing / Open Innovation". Berlin. |
2023-08-22 |
| Sartorius AG. (8/17/23). "Press Release: Sartorius and Repligen Corporation Launch Integrated System with Biostat STR and XCell ATF for Upstream Process Intensification". Göttingen. |
2023-08-17 |
| CureVac N.V.. (8/17/23). "Press Release: CureVac Announces Financial Results for the Second Quarter and First Half of 2023 and Provides Business Update". Tübingen & Boston, MA. |
2023-08-17 |
| BioNTech SE. (8/17/23). "Press Release: BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer". Tübingen & Boston, MA. |
2023-08-17 |
| Lindus Health Ltd.. (8/16/23). "Press Release: Announcing Our $18m Series A Led by Investors Creandum and with Participation from Peter Thiel". London. |
2023-08-16 |
| BiondVax Pharmaceuticals Ltd.. (8/11/23). "Press Release: BiondVax Reports Second Quarter Financial Results and Provides Business Update". Jerusalem. |
2023-08-11 |
| Novo Nordisk A/S. (8/10/23). "Press Release: Novo Nordisk to Acquire Inversago Pharma to Develop New Therapies for People Living with Obesity, Diabetes and other Serious Metabolic Diseases". Bagsværd & Montreal. |
2023-08-10 |
| Bactolife A/S. (8/8/23). "Press Release: Bactolife Raises EUR 30 Million in Series A Financing". Copenhagen. |
2023-08-08 |
| IO Biotech, Inc.. (8/7/23). "Press Release: IO Biotech, Inc. Announces $75 Million Private Placement Financing". New York, NY. |
2023-08-07 |
| Sartorius AG. (8/3/23). "Press Release: Florian Funck Appointed CFO of Sartorius. New CFO to Take Over as of April 2024". Göttingen. |
2023-08-03 |
| Temedica GmbH. (8/2/23). "Press Release: Temedica and AbbVie Germany Are Launching Digital Companion for Patients with Chronic Inflammatory Bowel Diseases". |
2023-08-02 |
| High-Tech Gründerfonds Management GmbH. (8/1/23). "Press Release: Bind-X Secures €10 Million in Financing as Part of Its Series B Financing Round". Martinsried. |
2023-08-01 |
| BiondVax Pharmaceuticals Ltd.. (8/1/23). "Press Release: Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules". Jerusalem. |
2023-08-01 |
| Sygnature Discovery Ltd.. (7/31/23). "Press Release: Sygnature Discovery Accelerates Global Growth with Major North American Acquisition". |
2023-07-31 |
| Qiagen N.V.. (7/26/23). "Press Release: Bio-Rad and Qiagen Announce Patent Settlement and Cross-licensing Agreement". Venlo. |
2023-07-26 |
| Immatics N.V.. (7/24/23). "Press Release: Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb". Tübingen & Houston, TX. |
2023-07-24 |
| Roche. (7/24/23). "Press Release: Roche Enters Partnership with Alnylam to Co-develop and Co-commercialise RNAi Therapeutic Zilebesiran to Treat Hypertension in Patients with High Cardiovascular Risk". Basel. |
2023-07-24 |
| Epigenomics AG. (7/24/23). "Press Release: Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets". Berlin. |
2023-07-24 |
| Idorsia Ltd.. (7/21/23). "Press Release: Idorsia Announces a Cost Reduction Initiative to Be Implemented by the End of 2023". Allschwil. |
2023-07-21 |
| Tillotts Pharma AG. (7/20/23). "Press Release: Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis". Montréal, Munich & Rheinfelden. |
2023-07-20 |
| ADC Therapeutics S.A.. (7/20/23). "Press Release: ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical Trial of Zynlonta (loncastuximab tesirine-lpyl) and Rituximab in Unfit or Frail Previously Untreated DLBCL Patients". Lausanne. |
2023-07-20 |
| Accession Therapeutics Ltd.. (7/19/23). "Press Release: Chief Business Officer Appointed at Accession Therapeutics as Company Prepares for Clinical Trials". Oxford. |
2023-07-19 |
| Bicycle Therapeutics plc. (7/18/23). "Press Release: Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Cambridg |
2023-07-18 |
| Leon-Nanodrugs GmbH. (7/18/23). "Press Release: Leon-Nanodrugs Appoints Dr. Hans Frickel as Chief Executive Officer". Munich. |
2023-07-18 |
| Argenx SE. (7/18/23). "Press Release: Argenx Raises $1.1 Billion in Gross Proceeds in a Global Offering". Amsterdam. |
2023-07-18 |
| Bioinformatics and Biotechnology Association Moldova. (7/18/23). "Press Release: Bioinformatics and Biotechnology Association Launched in the Republic of Moldova". Chisinau. |
2023-07-18 |
| Argenx SE. (7/17/23). "Press Release: Argenx Reports Positive Topline Data from ADHERE Study of Vyvgart Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy". Amsterdam. |
2023-07-17 |
| Novartis AG. (7/17/23). "Press Release: Novartis Builds on Neuroscience Pipeline and xRNA Platform Capabilities with Acquisition of DTx Pharma". Basel. |
2023-07-17 |
| Argenx SE. (7/17/23). "Press Release: Argenx Announces Launch of Proposed Global Offering". Amsterdam. |
2023-07-17 |
| Galmed Pharmaceuticals Ltd.. (7/14/23). "Press Release: Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering". Tel Aviv. |
2023-07-14 |
| CureVac N.V.. (7/14/23). "Press Release: CureVac Announces Update to the Management Team". Tübingen & Boston, MA. |
2023-07-14 |
| High-Tech Gründerfonds Management GmbH. (7/14/23). "Press Release: Pioneering Research Projects at the 8th Life Science Pitch Day at the IZB". Martinsried. |
2023-07-14 |
| Revvity, Inc.. (7/13/23). "Press Release: Revvity Establishes Scientific Centre of Excellence for Genomic Insight in Cambridge". Cambridge. |
2023-07-13 |
| BioGeneration Ventures B.V.. (7/13/23). "Press Release: BioGeneration Ventures Closes BGV Fund V at €150 Million". Naarden. |
2023-07-13 |
| Merck KGaA. (7/12/23). "Press Release: Merck Invests € 23 Million to Expand Cell Culture Media Production in Kansas, USA". Darmstadt. |
2023-07-12 |
| Bicycle Therapeutics plc. (7/12/23). "Press Release: Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares". Cambridge & Boston, MA. |
2023-07-12 |
| Bicycle Therapeutics plc. (7/12/23). "Press Release: Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares". Cambridge & Boston, MA. |
2023-07-12 |
| Tenpoint Therapeutics Ltd.. (7/12/23). "Press Release: Tenpoint Therapeutics Launches with $70 Million Series A Financing to Reverse Vision Loss Through Engineered Cell-based Therapeutics and In Vivo Reprogramming". London. |
2023-07-12 |
| ECBF Management GmbH. (7/11/23). "Press Release: Aphea.Bio, a Portfolio Company of VC Fund ECBF, Raises a Groundbreaking Series C Round of 70 Million Euros". Luxembourg. |
2023-07-11 |
| Biosynth AG. (7/11/23). "Press Release: Biosynth Expands Capabilities with Acquisition of Celares, Experts in Bioconjugation and Specialty Polymers". Staad. |
2023-07-11 |
| Evotec SE. (7/11/23). "Press Release: Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership". Hamburg. |
2023-07-11 |
| Abivax S.A.. (7/11/23). "Press Release: Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors". Paris. |
2023-07-11 |
| Nanobiotix S.A.. (7/10/23). "Press Release: Nanobiotix Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3". Paris & Cambridge, MA. |
2023-07-10 |
| Flash Therapeutics S.A.S.. (7/6/23). "Press Release: Flash Therapeutics Appoints Jérôme Bédier as Président to Accelerate Its Biopharmaceutical CDMO Business Development". Toulouse. |
2023-07-06 |
| AiCuris Anti-infective Cures AG. (7/6/23). "Press Release: AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients". Wuppertal. |
2023-07-06 |
| Numaferm GmbH. (7/6/23). "Press Release: Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides". |
2023-07-06 |
| Cellbox Solutions GmbH. (7/5/23). "Press Release: Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program". |
2023-07-05 |
| Camena Bioscience Ltd.. (7/3/23). "Press Release: Camena Bioscience Close $10 Series A Financing as Demand for DNA Synthesis Technology Increases". |
2023-07-03 |
| Gamma Biosciences. (6/30/23). "Press Release: Univercells Technologies Acquired by Donaldson Company". Menlo Park, CA. |
2023-06-30 |
| Donaldson Company, Inc.. (6/29/23). "Press Release: Donaldson Acquires Univercells Technologies, Broadens Life Sciences Reach". Minneapolis, MN. |
2023-06-29 |
| Mainz Biomed N.V.. (6/29/23). "Press Release: Mainz Biomed Secures up to $50M in New Funding". Berkeley, CA. |
2023-06-29 |
| Heidelberg Pharma AG. (6/29/23). "Press Release: Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics (ad hoc announcement)". Ladenburg. |
2023-06-29 |
| BioNTech SE. (6/29/23). "Press Release: BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC". Mainz & Rockville, MD. |
2023-06-29 |
| Gleamer S.A.S.. (6/28/23). "Press Release: Gleamer Raises €27 Million in Series B Funding Round to Expand Its AI Solutions Portfolio and Speed up International Expansion". Paris. |
2023-06-28 |
| MoonLake Immunotherapeutics AG. (6/28/23). "Press Release: MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares". Zug. |
2023-06-28 |
| EBAMed S.A.. (6/27/23). "Press Release: EBAMed, Swiss-Italian Company, Raises EUR 14.35 Million in Series A Funding to Develop Its Novel Image Guidance System for the Non-invasive Treatment of Ventricular Tachycardia through Proton Therapy". Zug. |
2023-06-27 |
| EBD Group. (6/27/23). "Press Release: BIO-Europe 2024 Is Going to Stockholm". Munich. |
2023-06-27 |
| AC Immune S.A.. (6/27/23). "Press Release: AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease". Lausanne. |
2023-06-27 |
| Astraveus S.A.S.. (6/27/23). "Press Release: Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of Its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform". Paris. |
2023-06-27 |
| Centogene N.V.. (6/27/23). "Press Release: Centogene and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE |
2023-06-27 |
| Helmholtz-Zentrum für Infektionsforschung (HZI. (6/27/23). "Press Release: Geneticist Josef Penninger Becomes New Scientific Director of the Helmholtz Centre for Infection Research". |
2023-06-27 |
| MoonLake Immunotherapeutics AG. (6/26/23). "Press Release: MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering". Zug. |
2023-06-26 |
| MoonLake Immunotherapeutics AG. (6/25/23). "Press Release: MoonLake Immunotherapeutics Achieves Landmark Milestone with Positive Phase 2 Results for Nanobody Sonelokimab in Hidradenitis Suppurativa". Zug. |
2023-06-25 |
| Abcam plc. (6/23/23). "Press Release: Abcam Announces Review of Strategic Alternatives". Cambridge & Waltham, MA. |
2023-06-23 |
| Bicycle Therapeutics plc. (6/23/23). "Press Release: Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer". Cambridge & Boston, MA. |
2023-06-23 |
| Tagworks Pharmaceuticals B.V.. (6/22/23). "Press Release: Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics". Nijmegen & Boston, MA. |
2023-06-22 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
